Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional steroid injections to prevent refractory strictures in patients with esophageal atresia
2018-002863-24Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of triamcinolone acetonide in Esophageal stricture (2 arms), sponsored by Erasmus MC. Primary endpoint: Total number of dilatations per patient within 28-day intervals during study period. Started Dec 2018; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
Esophageal stricture
Beyond the preview
Go deeper on 2018-002863-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002863-24.